However, it took whole - genome sequencing to identify
the second disease allele, a heterozygous ~ 55 kb deletion spanning at least three other exons in the gene.
Examples of compound heterozygous patients in which a
second, presumed null
allele is likely to contribute to
disease outcome are provided above in comparison to corresponding homo - or hemizygous patients with the same causative
allele.